(Q41879242)

13 October 2017

Efficacy of pentoxifylline for reduction of proteinuria in type II diabetic patients (English)

1 reference

13 October 2017

1 reference

Farshid Oliaei

1

1 reference

13 October 2017

Shirin Hushmand

series ordinal

2

1 reference

13 October 2017

Soraya Khafri

series ordinal

3

1 reference

13 October 2017

Mahmoud Baradaran

series ordinal

4

1 reference

13 October 2017

1 January 2011

1 reference

Caspian journal of internal medicine

13 October 2017

1 reference

13 October 2017

2

1 reference

13 October 2017

4

1 reference

13 October 2017

309-313

1 reference

The effect of pentoxifylline on proteinuria in diabetic kidney disease: a meta-analysis.

13 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3895828

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3895828

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3895828

Progression of diabetic nephropathy

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3895828

Urinary protein excretion and serum tumor necrosis factor in diabetic patients with advanced renal failure: effects of pentoxifylline administration

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3895828

Understanding the nature of renal disease progression

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3895828

Pentoxifylline. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3895828

Renal protective effect of enalapril in diabetic nephropathy

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3895828

Effect of pentoxifylline in addition to losartan on proteinuria and GFR in CKD: a 12-month randomized trial.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3895828

Dogma disputed: can aggressively lowering blood pressure in hypertensive patients with coronary artery disease be dangerous?

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3895828

Additive antiproteinuric effect of pentoxifylline in patients with type 2 diabetes under angiotensin II receptor blockade: a short-term, randomized, controlled trial

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3895828

Importance of baseline distribution of proteinuria in renal outcomes trials: lessons from the reduction of endpoints in NIDDM with the angiotensin II antagonist losartan (RENAAL) study

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3895828

Pentoxifylline improves hemoglobin levels in patients with erythropoietin-resistant anemia in renal failure

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3895828

Comparison of the effect of pentoxifylline and captopril on proteinuria in patients with type 2 diabetes mellitus

18 August 2018

1 reference

12 December 2020

Renoprotection in diabetes: genetic and non-genetic risk factors and treatment

1 reference

12 December 2020

Pentoxifylline in management of proteinuria in diabetic nephropathy

1 reference

12 December 2020

Pentoxifylline reduces proteinuria in insulin-dependent and non insulin-dependent diabetic patients

1 reference

12 December 2020

Will the addition of pentoxifylline reduce proteinuria in patients with diabetic glomerulosclerosis refractory to maximal doses of both an angiotensin-converting enzyme inhibitor and an angiotensin receptor blocker?

1 reference

12 December 2020

Arterial hypertension, microalbuminuria, and risk of ischemic heart disease

1 reference

12 December 2020

Renoprotective therapy: titration against urinary protein excretion

1 reference

12 December 2020

Identifiers

1 reference

13 October 2017

PubMed publication ID

24551437

1 reference